OTHERS MAH SING GROUP BERHAD ("MAH SING" OR "COMPANY") PROPOSED DIVERSIFICATION OF THE PRINCIPAL ACTIVITIES OF MAH SING TO INCLUDE MANUFACTURING AND TRADING OF GLOVES AND RELATED HEALTHCARE PRODUCTS ("GLOVES BUSINESS") ("PROPOSED DIVERSIFICATION")
| MAH SING GROUP BERHAD |
| Type | Announcement |
| Subject | OTHERS |
| Description | MAH SING GROUP BERHAD ("MAH SING" OR "COMPANY")
PROPOSED DIVERSIFICATION OF THE PRINCIPAL ACTIVITIES OF MAH SING TO INCLUDE MANUFACTURING AND TRADING OF GLOVES AND RELATED HEALTHCARE PRODUCTS ("GLOVES BUSINESS") ("PROPOSED DIVERSIFICATION") |
|
(For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcement dated 15 October 2020 in relation to the Proposed Diversification)
Further to our announcements on 15 October 2020 and 16 October 2020, Mah Sing wishes to provide additional information in connection to the Proposed Diversification. MSHSB's application for the US Food and Drug Administration (FDA) registration has been approved and is currently pending the issuance of certificate by Registrar Corp that MSHSB is registered with the FDA.
This announcement is dated 20 November 2020. |
|
Announcement Info
| Company Name | MAH SING GROUP BERHAD |
| Stock Name | MAHSING |
| Date Announced | 20 Nov 2020 |
| Category | General Announcement for PLC |
| Reference Number | GA1-20112020-00095 |